Literature DB >> 1924512

HAS and LAS rats respond differentially to behavioral effects of ethanol, pentobarbital, chlorpromazine and chlordiazepoxide.

E C Krimmer1.   

Abstract

The drug discrimination paradigm (DD) was used to evaluate differences in performance of rats selectively bred for differential sensitivity to the hypnotic effects of ethanol. Tenth generation high-alcohol sensitive (HAS) and low-alcohol sensitive (LAS) rats were trained to discriminate between ethanol (1.0 g/kg, IP) and saline vehicle on a VR-5 schedule of reinforcement. The HAS strain was more sensitive to the discriminative effects of ethanol than the LAS strain, but the magnitude of difference was much smaller than the differential sleep-time differences. The biphasic action of ethanol was differentially seen when the LAS animals exhibited increased activity during both DD and spontaneous motor activity measures and the HAS exhibited decreased activity during DD only. Pentobarbital and chlordiazepoxide but not chlorpromazine elicited the ethanol discriminative choice in both HAS and LAS strains. Response rates during DD indicated a dissociation of rate depressant effects and discriminative performance following ethanol. These findings are discussed in relationship to some current and future uses of selectively bred animal strains and DD for studying the effects of alcohol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924512     DOI: 10.1016/0091-3057(91)90389-j

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Phorbol ester differentiates the levels of [3H]MK-801 binding in rats lines selected for differential sensitivity to the hypnotic effects of ethanol.

Authors:  Seikwan Oh; Chia-Yu Chang; Rodney C Baker; Ing K Ho
Journal:  Neurochem Res       Date:  2005-02       Impact factor: 3.996

2.  Acute sensitivity and acute tolerance to ethanol in preweanling rats with or without prenatal experience with the drug.

Authors:  Carlos Arias; Juan Carlos Molina; Estela C Mlewski; Ricardo Marcos Pautassi; Norman Spear
Journal:  Pharmacol Biochem Behav       Date:  2008-02-23       Impact factor: 3.533

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.